SCHEDULE 13D/A: Saba Capital Reduces Stake in Nuveen Core Plus Impact Fund to 7.14%

Sentiment:

Beneficial Ownership Amendment


Saba Capital Management, L.P. and its affiliates have filed an Amendment No. 7 to their Schedule 13D, disclosing a reduction in their beneficial ownership of Nuveen Core Plus Impact Fund to 7.14% through a series of open market sales.

Worse than expectedA significant investor, Saba Capital, has reduced its stake in the Nuveen Core Plus Impact Fund by selling over 316,000 shares.While the current beneficial ownership remains above 5%, the reduction indicates a divestment, which can be perceived negatively by the market as it suggests a decrease in confidence or a change in investment strategy by a prominent activist fund.

Summary

  • Saba Capital Management, L.P., Saba Capital Management GP, LLC, and Boaz R. Weinstein (collectively, the "Reporting Persons") filed an Amendment No. 7 to their Schedule 13D regarding Nuveen Core Plus Impact Fund.
  • The filing reports the Reporting Persons' current beneficial ownership in Nuveen Core Plus Impact Fund as 2,053,350 Common Shares, which represents 7.14% of the outstanding common stock.
  • This percentage is calculated based on 28,755,000 shares of common stock outstanding as of June 30, 2024, as disclosed in the company's N-CSRS filed on September 5, 2024.
  • The amendment details open market sales of 316,403 Common Shares by Saba Capital between January 16, 2025, and February 6, 2025, with prices ranging from $10.46 to $10.90 per share.
  • The total approximate amount paid to acquire the Common Shares reported in the filing was $23,827,845.
  • Funds for the purchase of the Common Shares were derived from subscription proceeds from investors, capital appreciation, and margin account borrowings.

Sentiment

Score: 4

Explanation: The sentiment is slightly negative as a significant investor is reducing its stake, which could imply a less favorable outlook or a strategic exit from the position, potentially signaling a lack of confidence in the issuer's future performance from the investor's perspective.

Negatives

  • Saba Capital, a known activist investor, has reduced its stake in Nuveen Core Plus Impact Fund by selling 316,403 shares.
  • The reduction in stake by a significant investor could be perceived negatively by the market, potentially indicating a lack of confidence or a shift in investment strategy regarding the fund.

Future Outlook

NA

Industry Context

This filing reflects a common practice among activist or event-driven funds like Saba Capital, which often take significant stakes in closed-end funds to advocate for shareholder-friendly actions (e.g., tender offers, share repurchases, or open-ending the fund) and then reduce their positions once their objectives are met or the investment thesis changes. The reduction in stake could signal a shift in Saba Capital's strategy regarding Nuveen Core Plus Impact Fund or a realization of gains.

Legal Proceedings

  • The Reporting Persons (Saba Capital Management, L.P., Saba Capital Management GP, LLC, and Boaz R. Weinstein) have not been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors) during the last five years.
  • The Reporting Persons have not been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction that resulted in a judgment, decree, or final order enjoining future violations of, or prohibiting or mandating activities subject to, Federal or State securities laws or finding any violation with respect to such laws during the last five years.

Stakeholder Impact

  • Shareholders: The reduction in stake by a notable institutional investor like Saba Capital could lead to negative market sentiment and potentially impact the share price.

Key Dates

DateDescription
2015-11-16Date of power of attorney for Michael D'Angelo, incorporated by reference.
2015-12-28Date of initial Schedule 13G filing by the Reporting Persons.
2024-06-30Date as of which 28,755,000 common shares were outstanding, as disclosed in the company's N-CSRS.
2024-09-05Date of Nuveen Core Plus Impact Fund's N-CSRS filing disclosing shares outstanding.
2025-01-16Start date of the period for reported share sales by Saba Capital.
2025-02-06Date of event which required filing of this Schedule 13D/A (end date of reported share sales).
2025-02-10Date of signing of this Schedule 13D/A.

Recommendation

hold

Keywords

Nuveen Core Plus Impact Fund, Saba Capital Management, Schedule 13D/A, Beneficial Ownership, Institutional Investor, Fund Management, SEC Filing, Share Sales, Investment Fund

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.